People who drink 3-5 cups of coffee per day less likely to develop clogged arteries
the ONA take:
According to a new study published online in the journal Heart, researchers from Kangbuk Samsung Hospital in Seoul, South Korea, have found that people who drink a moderate amount of coffee each day, specifically three to five cups, are less likely to develop clogged arteries that could cause heart attacks.
For the study, researchers sought to investigate the association between coffee consumption and the presence of coronary artery calcium, an early indicator of coronary atherosclerosis.
They analyzed data from a group of 25,138 participants with an average age of 41 years who had no signs of heart disease. All participants attended a health screening examination which included a validated food frequency questionnaire and a multidetector cardiac computed tomography to determine levels of coronary artery calcium.
Results showed that participants who drank three to five cups of coffee per day had the lowest prevalence of clogged arteries, followed by those who drank one to three cups daily, less than one cup, and then those drank at least five cups or more per day compared with non coffee drinkers.
The findings suggest that coffee consumption may be inversely associated with cardiovascular disease risk, but further research is warranted to confirm these findings.
People who drink a moderate amount of coffee each day are less likely to develop clogged arteries that could cause heart attacks.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|